Methods for identifiying inhibitors of the MTOR pathway as diabetes therapeutics
摘要
The invention relates to inhibition of mTOR, p70S6K1 or Rheb kinase activity for treating disorders including diabetes. The invention also relates to screening for agents that inhibit the activities of mTOR, p70S6K1 or Rheb proteins, which are useful in the treatment of diabetes, as well as preparing compounds for treatment of diabetes.
申请公布号
WO2006020755(A3)
申请公布日期
2006.07.06
申请号
WO2005US28523
申请日期
2005.08.10
申请人
BETH ISRAEL DEACONESS MEDICAL CENTER, INC.;CANTLEY, LEWIS, C.;SHAW, REUBEN, J.;MANNING, BRENDAN, D.
发明人
CANTLEY, LEWIS, C.;SHAW, REUBEN, J.;MANNING, BRENDAN, D.